Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: DRREDDY and BSE: 500124 (ISIN INE089A01031).
It has a market capitalisation of ₹1.04 lakh crore, a last close of ₹1,243 on 2026-10-19, a one-year return of -1.1%.
Valuation: a price-to-earnings ratio of 32.20x, a price-to-book ratio of 2.74x, a dividend yield of 0.6%.
Profitability: return on equity of 11.7%, return on capital employed of 14.8%, an operating margin of 15.5%.
Growth: sales growth of 11.0% a year over three years, net profit growth of -2.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.17x, promoter holding of 26.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 1.04 L Cr |
| Last close | ₹1,243 |
| P/E (TTM) | 32.20x |
| P/B | 2.74x |
| Dividend yield | 0.6% |
| ROE (FY) | 11.7% |
| ROCE (FY) | 14.8% |
| Operating margin (TTM) | 15.5% |
| Sales growth, 3-year CAGR | 11.0% |
| Profit growth, 3-year CAGR | -2.4% |
| Debt / equity | 0.17x |
| Promoter holding | 26.6% |
| 1-year return | -1.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means